QLT Inc. to Present at the J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia, Jan. 9, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) will be presenting at the 30th Annual J.P.Morgan Healthcare Conference in San Francisco on Thursday, January 12, 2012, at 8:00 a.m. Pacific Time. Bob Butchofsky, QLT's President and Chief Executive Officer, will be discussing the Company's two primary development programs: (i) a synthetic retinoid, QLT091001, for the treatment of Leber Congenital Amaurosis and Retinitis Pigmentosa; and (ii) the Company's Punctal Plug Delivery System for the treatment of glaucoma.